Evaluation of an intermittent schedule of mitolactol in advanced non-small cell lung cancer

Cancer Treat Rep. 1981 Nov-Dec;65(11-12):1099-1101.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adult
  • Aged
  • Carcinoma, Small Cell / drug therapy
  • Carcinoma, Squamous Cell / drug therapy
  • Drug Administration Schedule
  • Drug Evaluation
  • Female
  • Humans
  • Leukopenia / chemically induced
  • Lung Neoplasms / complications
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Male
  • Middle Aged
  • Mitolactol / administration & dosage*
  • Mitolactol / adverse effects
  • Thrombocytopenia / chemically induced

Substances

  • Mitolactol